Dextrose Injection, Solution
Product Images NDC 0338-9649

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0338-9649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dextrose Hydrous Structural Formula (Image 01)

Chemical structure diagram of Dextrose Hydrous, also known as D-glucose monohydrate, the active ingredient in DEXTROSE injection solution for intravenous use by Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label 0338-9651-75 (Image 02)

Label for DEXTROSE 5% Injection USP, an intravenous injection solution containing 5 g dextrose per 100 mL. This sterile, non-pyrogenic single-dose container holds 250 mL. Manufactured by Baxter Healthcare Corporation, the label includes storage, administration, and safety instructions, along with contact information and lot/expiry fields. The solution's osmolality is 252 mOsm/L with a pH range of 4.0 to 6.5.*

FDA Label Image

Representative Carton Label 0338-9651-75 (Image 03)

5% Dextrose Injection USP solution, 250 mL single-dose container for intravenous use. The label shows a 5 g per 100 mL dextrose monohydrate concentration, pH 4.0 (3.2-6.5) with osmolarity 252 mOsm/L. Manufactured by Baxter Healthcare Corporation, labeled as sterile and nonpyrogenic. Additional usage and caution instructions are included on the label.*

FDA Label Image

Representative Container Label 0338-9649-75 (Image 04)

Label for DEXTROSE 5% Injection USP, a 500 mL intravenous injection solution containing 5 g dextrose monohydrate per 100 mL. The label indicates the product is sterile, non-pyrogenic, single-dose, manufactured by Baxter Healthcare Corporation, made in Spain. It includes storage instructions, usage warnings, and company contact info.*

FDA Label Image

Representative Carton Label 0338-9649-75 (Image 05)

Label for 5% Dextrose Injection USP 500 mL intravenous solution by Baxter Healthcare Corporation. It lists active ingredient dextrose monohydrate, pH 4.0, osmolarity 252 mOsm/L, sterile single-dose container, and usage/storage instructions. The label also provides manufacturer contact and lot/expiry information.*

FDA Label Image

Representative Container Label 0338-9655-60 (Image 06)

Label for 5% Dextrose Injection USP, 1000 mL intravenous solution by Baxter Healthcare Corporation. The sterile, nonpyrogenic solution contains 5 g dextrose monohydrate per 100 mL. The label includes storage instructions, cautions about additives and administration, and manufacturer details, stating it is made in Spain and distributed by Baxter Healthcare Corporation, Deerfield, IL.*

FDA Label Image

Representative Carton Label 0338-9655-60 (Image 07)

Label for Dextrose 5% Injection USP, 1000 mL intravenous solution by Baxter Healthcare Corporation. Contains 5 g dextrose monohydrate per 100 mL. The sterile, non-pyrogenic, single-dose container is indicated for intravenous use. Label includes storage instructions, warnings, and manufacturer contact information, with product made in Spain.*

FDA Label Image

Representative Container Label 0338-9653-60 (Image 08)

Label for 5% Dextrose Injection USP 100 mL intravenous solution by Baxter Healthcare Corporation. The label states it contains 5 g Dextrose Hydrous USP per 100 mL, with pH and osmolarity values given. Instructions and warnings about use, storage, and additives incompatibility are included. The product is sterile, non-pyrogenic, single dose, and made in Spain.*

FDA Label Image

Representative Carton Label 0338-9653-60 (Image 09)

Label for 5% Dextrose Injection, USP, 5 g/100 mL IV solution by Baxter Healthcare Corporation. The label shows packaging of 60 x 100 mL units (approximately 8 kg total). It includes formulation details, manufacturer information (Baxter Healthcare, Deerfield IL, made in Spain), and cautions such as reading the package insert and keeping out of reach of children. Lot and expiration date fields are blank.*

FDA Label Image

Representative Container Label 0338-0062-30 (Image 10)

Label for Dextrose 5% Injection USP, an intravenous injection solution with 250 mL volume. It contains 5 g dextrose monohydrate per 100 mL and is labeled with pH 4.0 and osmolarity 252 mOsm/L. The product is by Baxter Healthcare Corporation, made in Spain, and intended for single dose use in sterile, nonpyrogenic containers.*

FDA Label Image

Representative Container Label 0338-0074-30 (Image 11)

Drug Facts panel for 5% Dextrose Injection USP, 250 mL. The label shows solution pH (4.0), osmolarity, and dosage strength (5 g Dextrose Hydrous USP per 100 mL). It includes storage instructions, usage cautions, single-dose container warning, and manufacturer information for Baxter Healthcare Corporation. The product is sterile and nonpyrogenic.*

FDA Label Image

Representative Container Label 0338-0066-20 (Image 12)

Label for Dextrose 5% Injection USP, 500 mL intravenous solution by Baxter Healthcare Corporation. Contains 5 g dextrose per 100 mL, sterile in a nonpyrogenic single-dose container. Label includes storage instructions, cautions, and manufacturer contact information. Made in Spain.*

FDA Label Image

Representative Container Label 0338-0078-20 (Image 13)

Label for 5% Dextrose Injection USP, 500 mL intravenous solution by Baxter Healthcare Corporation. The label indicates a pH of 4.0, osmolarity of 252 mOsm/L, and contains instructions and warnings about use, storage, and additives. The product is sterile, nonpyrogenic, and in a single-dose container. Contact and manufacturing details are provided, including that it is made in Spain.*

FDA Label Image

Representative Container Label 0338-0070-10 (Image 14)

Label for DEXTROSE 5% Injection USP, an intravenous solution containing 5 g dextrose monohydrate per 100 mL. The sterile, nonpyrogenic single-dose container has a volume of 1000 mL. Manufactured by Baxter Healthcare Corporation, it has a pH range of 4.0 (3.2-6.5) and osmolarity of 252 mOsm/L (calculated). The label includes storage, usage, and caution information.*

FDA Label Image

Representative Container Label 0338-0082-10 (Image 15)

Label for 5% Dextrose Injection USP, 1000 mL intravenous solution, containing 5 g dextrose monohydrate per 100 mL. Distributed by Baxter Healthcare Corporation, made in Spain. The label includes storage instructions, usage cautions, and regulatory information for the single-dose, sterile nonpyrogenic container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.